Ben-yan Zou
State Key Laboratory Of Oncology In South China
Guangzhou, China
Guangzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Safety and Clinical Activity of SHR7390 Monotherapy or Combined With Camrelizumab for Advanced Solid Tumor: Results From Two Phase I Trials.
Journal: The oncologist
Published: July 22, 2021
A phase I study of toripalimab, an anti-PD-1 antibody, in patients with refractory malignant solid tumors.
Journal: Cancer communications (London, England)
Published: April 21, 2020
Puquitinib mesylate, an inhibitor of phosphatidylinositol 3-kinase p110δ, for treating relapsed or refractory non-Hodgkin's lymphoma.
Journal: Oncotarget
Published: July 20, 2015
Phase I dose-escalation study of aflibercept plus docetaxel in nasopharyngeal carcinoma and other solid tumors.
Journal: Future oncology (London, England)
Published: December 23, 2014
Prognostic significance of thymidylate synthase in postoperative non-small cell lung cancer patients.
Journal: OncoTargets and therapy
Published: August 13, 2014
Quantification of photocyanine in human serum by high-performance liquid chromatography-tandem mass spectrometry and its application in a pharmacokinetic study.
Journal: Journal of analytical methods in chemistry
Published: February 14, 2014
Determination of photocyanine in human serum by HPLC and application to pharmacokinetic study.
Journal: Journal of chromatographic science
Published: July 27, 2013
Phase I clinical trial of the novel platin complex dicycloplatin: clinical and pharmacokinetic results.
Journal: International journal of clinical pharmacology and therapeutics
Published: November 07, 2012
Serum beta2-microglobin is a predictor of prognosis in patients with upper aerodigestive tract NK/T-cell lymphoma.
Journal: Annals of hematology
Published: December 19, 2011
Cyclosporine, prednisone, and high-dose immunoglobulin treatment of angioimmunoblastic T-cell lymphoma refractory to prior CHOP or CHOP-like regimen.
Journal: Chinese journal of cancer
Published: October 01, 2011
Showing 1-11 of 11
Last Updated: 09/26/2026